Ján Vilček
Ján Vilček · Science & Medicine
Biomedical scientist whose interferon and anti-TNF research led to the arthritis drug Remicade.
1933, Bratislava, Czechoslovakia (now Slovakia)
Slovakia · United States
Ján Vilček is recognized among Jewish contributors to Science & Medicine — Biomedical scientist whose interferon and anti-TNF research led to the arthritis drug Remicade.
Ján Vilček is a biomedical scientist whose research on interferons and on tumour necrosis factor led to the anti-TNF antibody that became the arthritis and Crohn's-disease drug Remicade (infliximab). Royalties from that work funded major philanthropy for science and the arts. He is Jewish, a Holocaust survivor who was hidden as a child in wartime Slovakia before emigrating to the United States.
Verify and go deeper with these external references.
Source: Jinfo.org — Jews in Biology
This page is published in seven languages from an English source. The translations are reviewed, but a mistake can still slip through. If you spot one on this profile — a wrong word, a lost date, a sentence that says something the English does not — please tell us.
Biomedical scientist whose interferon and anti-TNF research led to the arthritis drug Remicade.
Source: Jinfo.org — Jews in Biology
Similar Contributors
Barry Coller
Bernard G. Sarnat
